Skip to content

Clinical trials

Completed Phase 2 Narcolepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Narcolepsy Phase: Phase 2 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20111
20121
20162
20171
20193
20212
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals3
Alkermes, Inc.2
NLS Pharmaceutics2
Alza Corporation, DE, USA1
Axsome Therapeutics, Inc.1
Emory University1
Lynn Marie Trotti1
Pfizer1
Suven Life Sciences Limited1
Taisho Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Narcolepsy15
Disorders of Excessive Somnolence7
Cataplexy3
Idiopathic Hypersomnia2
Sleep Wake Disorders1
Sleepiness1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.